Inventor
WILDMANN CLAUDE
BE5 patents
Patents
5 patentsUS6638512B1Oct 28, 2003
Method for treating subjects by using BAGE tumor rejection antigen precursors or tumor rejection antigens
LUDWIG INST CANCER RES1 citations61
US6465184B1Oct 15, 2002
Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecules HLA-Cw*1601 and uses thereof
LUDWIG INST CANCER RES2 citations61
US6110694AAug 29, 2000
Methods for determining complexes of tumor rejection antigens and HLA-Cw*160/molecules
LUDWIG INST CANCER RES2 citations61
US5877017AMar 2, 1999
Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw*1601 and uses thereof
LUDWIG INST CANCER RES1 citations50
US6680056B1Jan 20, 2004
Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of hla-cw 1601/mage-1 derived peptides, and methods for treating said individuals
LUDWIG INST CANCER RES0 citations49